BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32321380)

  • 1. IFITM3 affects the level of antibody response after influenza vaccination.
    Lei N; Li Y; Sun Q; Lu J; Zhou J; Li Z; Liu L; Guo J; Qin K; Wang H; Zhao J; Li C; Sun L; Wang D; Zhao Z; Shu Y
    Emerg Microbes Infect; 2020 Dec; 9(1):976-987. PubMed ID: 32321380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults.
    Qin L; Wang D; Li D; Zhao Y; Peng Y; Wellington D; Dai Y; Sun H; Sun J; Liu G; McMichael A; Dong T; Zhang Y
    Front Cell Infect Microbiol; 2018; 8():134. PubMed ID: 29868492
    [No Abstract]   [Full Text] [Related]  

  • 3. The truncated IFITM3 facilitates the humoral immune response in inactivated influenza vaccine-vaccinated mice via interaction with CD81.
    Xie Q; Liao X; Huang B; Wang L; Liao G; Luo C; Wen S; Fang S; Luo H; Shu Y
    Emerg Microbes Infect; 2023 Dec; 12(2):2246599. PubMed ID: 37556756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No Correlation of the Disease Severity of Influenza A Virus Infection with the rs12252 Polymorphism of the Interferon-Induced Transmembrane Protein 3 Gene.
    Kim YC; Jeong BH
    Intervirology; 2017; 60(1-2):69-74. PubMed ID: 28813716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFITM3 restricts the morbidity and mortality associated with influenza.
    Everitt AR; Clare S; Pertel T; John SP; Wash RS; Smith SE; Chin CR; Feeley EM; Sims JS; Adams DJ; Wise HM; Kane L; Goulding D; Digard P; Anttila V; Baillie JK; Walsh TS; Hume DA; Palotie A; Xue Y; Colonna V; Tyler-Smith C; Dunning J; Gordon SB; ; ; Smyth RL; Openshaw PJ; Dougan G; Brass AL; Kellam P
    Nature; 2012 Mar; 484(7395):519-23. PubMed ID: 22446628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection.
    Makvandi-Nejad S; Laurenson-Schafer H; Wang L; Wellington D; Zhao Y; Jin B; Qin L; Kite K; Moghadam HK; Song C; Clark K; Hublitz P; Townsend AR; Wu H; McMichael AJ; Zhang Y; Dong T
    J Infect Dis; 2018 Jan; 217(2):257-262. PubMed ID: 29202190
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Pan Y; Yang P; Dong T; Zhang Y; Shi W; Peng X; Cui S; Zhang D; Lu G; Liu Y; Wu S; Wang Q
    Front Cell Infect Microbiol; 2017; 7():294. PubMed ID: 28713779
    [No Abstract]   [Full Text] [Related]  

  • 8. Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
    David S; Correia V; Antunes L; Faria R; Ferrão J; Faustino P; Nunes B; Maltez F; Lavinha J; Rebelo de Andrade H
    Immunogenetics; 2018 Mar; 70(3):169-177. PubMed ID: 28842783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.
    Sun X; Zeng H; Kumar A; Belser JA; Maines TR; Tumpey TM
    J Virol; 2016 Dec; 90(24):11157-11167. PubMed ID: 27707929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferon-inducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus.
    Kim YC; Jeong BH
    Immunogenetics; 2020 Dec; 72(9-10):447-453. PubMed ID: 33174121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFITM3 polymorphism rs12252-C restricts influenza A viruses.
    Williams DE; Wu WL; Grotefend CR; Radic V; Chung C; Chung YH; Farzan M; Huang IC
    PLoS One; 2014; 9(10):e110096. PubMed ID: 25314048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort.
    Zhang Y; Makvandi-Nejad S; Qin L; Zhao Y; Zhang T; Wang L; Repapi E; Taylor S; McMichael A; Li N; Dong T; Wu H
    AIDS; 2015 May; 29(8):889-94. PubMed ID: 25784441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Islam S; Mohn KG; Krammer F; Sanne M; Bredholt G; Jul-Larsen Å; Tete SM; Zhou F; Brokstad KA; Cox RJ
    Vaccine; 2017 Oct; 35(42):5666-5673. PubMed ID: 28899626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
    Front Immunol; 2018; 9():2465. PubMed ID: 30405641
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
    Randolph AG; Yip WK; Allen EK; Rosenberger CM; Agan AA; Ash SA; Zhang Y; Bhangale TR; Finkelstein D; Cvijanovich NZ; Mourani PM; Hall MW; Su HC; Thomas PG; ;
    J Infect Dis; 2017 Jul; 216(1):14-21. PubMed ID: 28531322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults.
    Frenck RW; Belshe R; Brady RC; Winokur PL; Campbell JD; Treanor J; Hay CM; Dekker CL; Walter EB; Cate TR; Edwards KM; Hill H; Wolff M; Leduc T; Tornieporth N
    Vaccine; 2011 Aug; 29(34):5666-74. PubMed ID: 21699951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-Inducible Transmembrane Protein 3 Genetic Variant rs12252 and Influenza Susceptibility and Severity: A Meta-Analysis.
    Yang X; Tan B; Zhou X; Xue J; Zhang X; Wang P; Shao C; Li Y; Li C; Xia H; Qiu J
    PLoS One; 2015; 10(5):e0124985. PubMed ID: 25942469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.